NRX Pharmaceuticals, Inc. (NRXP) stock
NRXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.15−0.04 (-1.83%)
Close on Nov 16, 2026Market cap $93.09MP/E –Yield –
NRX Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
NRX Pharmaceuticals's operating margin for the twelve months ending Jun 30, 2026 was -586.2%. For fiscal 2025 it was -1324.4%.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1324.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -590.8% | – |
| Q1 FY2026 | Mar 31, 2026 | -444.0% | – |
| Q4 FY2025 | Dec 31, 2025 | -470.4% | – |
| Q3 FY2025 | Sep 30, 2025 | -1662.8% | – |
See a number that looks wrong?